NEW YORK, Dec. 21, 2018 (GLOBE NEWSWIRE) — News Commentary www.cannagreed.com
In 1994, the American Pet Products Association (APPA) says Americans spent $17 billion on their pets. By 2016 that number grew to $66.75 billion. In 2017 it is estimated at $69.36 billion.
The (APPA) estimates spending by 2020 could surpass $96 billion in sales. With numbers like that along with pet parents looking for ways to improve their pets' healthier lifestyles, it makes perfect sense for manufacturers of CBD to enter the pet space.
The rapid expansion of treating pets with alternative medicine is fueling interest, desire, and conversations amongst pet parents and the veterinary community. What is really driving interested pet parents is the fact that dogs with certain afflictions are treated with CBD with great success!
As evidence continues to surface over the benefits of CBD for humans, more and more people are turning their attention to what it can do for pets. CBD for domesticated animals, most notably cats and dogs, is gaining considerably more attention from consumers, and, in turn, the cannabis industry. With pet owners spending more than $30 billion a year on supplements and other types of treatments, it is a fast-growing sector that businesses cannot ignore.
According to MinistryofHemp.com CBD has a whole host of possible uses when it comes to pets. Some of them include helping with such ailments as:
- Skin Problems
According to the site, many veterinarians have found that CBD can help older pets with joint pain. In the words of MinistryofHemp.com, “[CBD is] useful in treating acute ailments like sprains and strains, torn ligaments, bone breaks, and even during post-operative care to reduce swelling, pain, and stiffness.”
CBD works in both humans and pets through interaction with the endocannabinoid system. Science now shows that all vertebrates have one. According to one study CBD “binds to these receptors for a longer duration [in dogs], and evokes long-lasting therapeutic response without causing toxic effects.”
EnviroTechnologies International, Inc. (OTC:ETII) is showing momentum again. Taking into consideration the previous share price spikes in January-February and March 2018, the bullish thesis is drawing the attention of the market. In addition, the recent increase in the daily trading average volume also shows that market interest is growing around this stock.
EnviroTechnologies International, Inc. (OTC:ETII), has already one foot in the rapidly expanding sixty-billion-dollar CBD pet industry market.
After a year of ups and downs in the market, its recent acquisition (CBD Health Co.) has put the company back in the spotlight. In a recent press release, the company confirmed that its subsidiary, CBD Health Co., (www.cbdhealthco.com), a company that markets and sells high quality and proprietary hemp-based, natural CBD health products, is progressing in its hemp-based pet supplement products development.
“Much has been written lately about CBD products and the numerous applications for humans and pets, which has raised consciousness of CBD's therapeutic value. Our CBD products are all cannabidiol-based, which means they are not psychoactive and are safe for pets,” said Joe De Leon, CBD's President.
“When your pet gets sick, you want the best treatment available and the products we are developing will offer better, more effective and safer medicinal options for pets than traditional pet health products.”
The company ( ETII ) intend to work closely with veterinarian doctors attending trade shows, and launching national campaigns to penetrate the market. Along the way we will educate the public on safe and natural ways to treat their pets.
The green rush is upon us, and EnviroTechnologies International, Inc. is worth keeping a close eye on this month.
Full Disclaimer: http://www.cannagreed.com/disclaimer/
Source: EnviroTechnologies International, Inc